NCT06373406View on ClinicalTrials.gov

A Study of MHB036C for Advanced Solid Tumor

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 18, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions
Advanced Solid Tumor
Interventions
DRUG

MHB036C

An antibody-drug conjugate therapy

Trial Locations (1)

200030

RECRUITING

Shanghai Chest Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

Minghui Pharmaceutical (Hangzhou) Ltd

INDUSTRY

NCT06373406 - A Study of MHB036C for Advanced Solid Tumor | Biotech Hunter | Biotech Hunter